Immunology connects with themes related to Interleukin 4 in his study. He merges Interleukin 4 with Interleukin 5 in his research. Gerald J. Berry integrates many fields in his works, including Interleukin 5 and Allergy. He performs integrative Allergy and Allergen research in his work. Gerald J. Berry integrates many fields, such as Allergen and Asthma, in his works. His work blends Asthma and Allergic inflammation studies together. While working in this field, Gerald J. Berry studies both Allergic inflammation and Eosinophil. His multidisciplinary approach integrates Eosinophil and Eosinophilic in his work. He combines Eosinophilic and Cytokine in his research.
His Biochemistry research includes a combination of various areas of study, such as Pharmacology and Gene. While working in this field, Gerald J. Berry studies both Pharmacology and Biochemistry. Gerald J. Berry undertakes interdisciplinary study in the fields of Internal medicine and Cardiology through his works. Gerald J. Berry conducts interdisciplinary study in the fields of Cardiology and Internal medicine through his research. By researching both Immunology and Virus, Gerald J. Berry produces research that crosses academic boundaries. In his works, Gerald J. Berry undertakes multidisciplinary study on Pathology and Biopsy. His work often combines Biopsy and Pathology studies. Gerald J. Berry frequently studies issues relating to Surgery and Transplantation. Many of his studies involve connections with topics such as Transplantation and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection
Susan Stewart;Michael C. Fishbein;Gregory I. Snell;Gerald J. Berry.
Journal of Heart and Lung Transplantation (2005)
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions
M. Haas;B. Sis;L. C. Racusen;K. Solez.
American Journal of Transplantation (2014)
Revision of the 1990 working formulation for the classification of pulmonary allograft rejection : Lung Rejection Study Group
S. A. Yousem;G. J. Berry;Philip T. Cagle;D. Chamberlain.
Journal of Heart and Lung Transplantation (1996)
Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity
Omid Akbari;Gordon J. Freeman;Everett H. Meyer;Edward A. Greenfield.
Nature Medicine (2002)
Idiopathic Giant-Cell Myocarditis — Natural History and Treatment
Leslie T. Cooper;Gerald J. Berry;Ralph Shabetai.
The New England Journal of Medicine (1997)
Allergen-specific Th1 cells fail to counterbalance Th2 cell–induced airway hyperreactivity but cause severe airway inflammation
Gesine Hansen;Gerald Berry;Rosemarie H. DeKruyff;Dale T. Umetsu.
Journal of Clinical Investigation (1999)
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Kun-Hsing Yu;Ce Zhang;Gerald J. Berry;Russ B. Altman.
Nature Communications (2016)
Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
T. Safra;F. Muggia;S. Jeffers;D. D. Tsao-Wei.
Annals of Oncology (2000)
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Frank Diet;Richard E. Pratt;Gerald J. Berry;Naoko Momose.
CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma.
Omid Akbari;John L. Faul;Elisabeth G. Hoyte;Gerald J. Berry.
The New England Journal of Medicine (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: